LifeStance Health Q2 revenue beats on higher visit volumes
LifeStance Health Q2 revenue beats on higher visit volumes
Overview
U.S. outpatient mental healthcare provider's Q2 revenue grew 26%, beating analyst expectations
Q2 adjusted EBITDA nearly doubled yr/yr and beat analyst expectations
Company announced new $100 mln share repurchase program
Outlook
LifeStance Health raises 2026 revenue guidance to $1.685 bln-$1.725 bln
Company expects Q3 revenue of $420 mln-$440 mln
LifeStance Health sees 2026 Adjusted EBITDA of $215 mln-$235 mln
Result Drivers
VISIT VOLUME - Co said revenue growth was mainly driven by higher visit volumes from net clinician growth
CLINICIAN PRODUCTIVITY - Co cited improved clinician productivity as a contributor to revenue growth
OPERATING LEVERAGE - Adjusted EBITDA margin increased due to higher revenue per visit, lower center costs as a percentage of revenue, and improved operating leverage from revenue growing faster than general and administrative expenses
Company press release: ID:nGNX9V3TTc
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $435.40 mln | $414.58 mln (9 Analysts) |
Q2 EPS |
| $0.06 |
|
Q2 Net Income |
| $23.60 mln |
|
Q2 Adjusted EBITDA | Beat | $66 mln | $54.21 mln (9 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for LifeStance Health Group, Inc. is $13.00, about 25.4% above its August 5 closing price of $10.37
The stock recently traded at 51 times the next 12-month earnings vs. a P/E of 77 three months ago
Reuters Recommended Reads
Aug 4 - Hinge Health Q2 revenue jumps 53%, beats estimates
Aug 4 - Amwell Q2 revenue falls, co lifts low end of FY guidance
Aug 5 - Compass Pathways' Q2 loss widens on commercial readiness activity costs
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)